RI
RTW Investments’s Adverum Biotechnologies ADVM Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-223,725
| Closed | -$293K | – | 108 |
|
2022
Q1 | $293K | Sell |
223,725
-7,331,092
| -97% | -$9.6M | 0.01% | 103 |
|
2021
Q4 | $13.3M | Buy |
7,554,817
+71,060
| +0.9% | +$125K | 0.19% | 76 |
|
2021
Q3 | $16.2M | Buy |
7,483,757
+125,840
| +2% | +$273K | 0.24% | 68 |
|
2021
Q2 | $25.8M | Buy |
7,357,917
+8,941
| +0.1% | +$31.3K | 0.39% | 53 |
|
2021
Q1 | $72.5M | Buy |
7,348,976
+121,612
| +2% | +$1.2M | 1.13% | 30 |
|
2020
Q4 | $78.3M | Sell |
7,227,364
-7,400
| -0.1% | -$80.2K | 1.31% | 24 |
|
2020
Q3 | $74.5M | Buy |
7,234,764
+444,737
| +7% | +$4.58M | 1.79% | 17 |
|
2020
Q2 | $142M | Buy |
6,790,027
+158,400
| +2% | +$3.31M | 3.99% | 5 |
|
2020
Q1 | $64.8M | Buy |
6,631,627
+245,020
| +4% | +$2.39M | 2.79% | 12 |
|
2019
Q4 | $73.6M | Buy |
6,386,607
+105,604
| +2% | +$1.22M | 2.78% | 11 |
|
2019
Q3 | $34.2M | Sell |
6,281,003
-39,347
| -0.6% | -$214K | 2.04% | 18 |
|
2019
Q2 | $75.1M | Buy |
6,320,350
+63,510
| +1% | +$755K | 4.01% | 8 |
|
2019
Q1 | $32.8M | Hold |
6,256,840
| – | – | 2.24% | 15 |
|
2018
Q4 | $19.7M | Buy |
6,256,840
+6,072,019
| +3,285% | +$19.1M | 1.81% | 16 |
|
2018
Q3 | $1.12M | Buy |
184,821
+8,449
| +5% | +$51.1K | 0.07% | 44 |
|
2018
Q2 | $935K | Buy |
176,372
+1,164
| +0.7% | +$6.17K | 0.07% | 39 |
|
2018
Q1 | $1.02M | Buy |
+175,208
| New | +$1.02M | 0.1% | 37 |
|
2015
Q2 | – | Sell |
-51,300
| Closed | -$2.08M | – | 33 |
|
2015
Q1 | $2.08M | Buy |
51,300
+1,300
| +3% | +$52.7K | 0.94% | 14 |
|
2014
Q4 | $2.7M | Buy |
+50,000
| New | +$2.7M | 1% | 14 |
|